Axogen Inc - Asset Resilience Ratio
Axogen Inc (AXGN) has an Asset Resilience Ratio of 6.55% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Axogen Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Axogen Inc's Asset Resilience Ratio has changed over time. See Axogen Inc balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Axogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Axogen Inc (AXGN) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $18.95 Million | 6.55% |
| Total Liquid Assets | $18.95 Million | 6.55% |
Asset Resilience Insights
- Limited Liquidity: Axogen Inc maintains only 6.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Axogen Inc Industry Peers by Asset Resilience Ratio
Compare Axogen Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Axogen Inc (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Axogen Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.70% | $5.98 Million | $221.69 Million | -0.21pp |
| 2024-12-31 | 2.91% | $5.93 Million | $203.73 Million | +5.96pp |
| 2023-12-31 | -3.05% | $-6.00 Million | $196.83 Million | -20.20pp |
| 2022-12-31 | 17.15% | $33.51 Million | $195.39 Million | -7.53pp |
| 2021-12-31 | 24.68% | $51.33 Million | $208.02 Million | -2.74pp |
| 2020-12-31 | 27.41% | $55.20 Million | $201.38 Million | -11.90pp |
| 2019-12-31 | 39.31% | $60.79 Million | $154.64 Million | -18.32pp |
| 2018-12-31 | 57.63% | $92.31 Million | $160.17 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $58.87 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $46.36 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $37.55 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $16.40 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $27.68 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $20.23 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $12.50 Million | -- |
About Axogen Inc
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed periphera… Read more